We showed here that protumoral CD163+ MΦs predominate, at diagnosis, in the BM of AML patients and that the induction of CD163 expression on MΦs by myeloblasts was dependent on CSF1R. This evidence concerns the gene CD163 and acute myeloid leukemia.